Ipsen obtains exclusive options to Spherical Nucleic Acids currently under discovery evaluation for Huntington s disease and Angelman syndrome Exicure.
People afflicted with autoimmune diseases may someday receive help through treatments now under development by a Lawrence Livermore National Laboratory licensee and its' collaborations with two major pharmaceutical companies.